Sale!

ATP2A1 Gene Brody Myopathy Genetic Test

4,400 د.إ

-21%

The ATP2A1 gene plays a crucial role in muscle function and is associated with Brody myopathy, a rare genetic disorder characterized by muscle stiffness and fatigue following exercise. The disorder results from mutations in the ATP2A1 gene, which encodes an enzyme crucial for muscle relaxation. Identifying mutations in this gene is essential for diagnosing Brody myopathy accurately.

DNA Labs UAE offers a genetic test specifically designed to detect mutations in the ATP2A1 gene, aiding in the diagnosis of Brody myopathy. The test is conducted through a detailed analysis of the individual’s genetic material, usually obtained via a blood sample. This test is pivotal for individuals experiencing symptoms of Brody myopathy or those with a family history of the condition, as it can confirm the diagnosis and facilitate appropriate management and treatment plans.

The cost of the ATP2A1 gene test for Brody myopathy at DNA Labs UAE is 4400 AED. This investment covers the comprehensive genetic analysis and the professional interpretation of the results, ensuring individuals and their healthcare providers have the necessary information for an informed approach to managing the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ATP2A1 Gene Brody Myopathy Genetic Test

Components

  • Test Name: ATP2A1 Gene Brody Myopathy Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for ATP2A1 Gene Brody Myopathy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATP2A1 Gene Brody Myopathy

Test Details

The ATP2A1 gene is responsible for encoding the sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1) protein, which plays a crucial role in muscle contraction and relaxation. Mutations in the ATP2A1 gene can lead to Brody myopathy, a rare autosomal recessive disorder characterized by exercise-induced muscle stiffness and cramps.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and detect genetic mutations associated with various diseases, including Brody myopathy. NGS testing can identify both common and rare genetic variants in the ATP2A1 gene, providing a comprehensive analysis of the patient’s genetic profile.

NGS genetic testing for Brody myopathy typically involves collecting a blood or saliva sample from the patient, which is then analyzed using advanced sequencing technology. The results of the test can help diagnose Brody myopathy, guide treatment decisions, and inform genetic counseling for the patient and their family members.

Test Name ATP2A1 Gene Brody myopathy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ATP2A1 Gene Brody myopathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATP2A1 Gene Brody myopathy
Test Details

The ATP2A1 gene is responsible for encoding the sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1) protein, which plays a crucial role in muscle contraction and relaxation. Mutations in the ATP2A1 gene can lead to Brody myopathy, a rare autosomal recessive disorder characterized by exercise-induced muscle stiffness and cramps.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and detect genetic mutations associated with various diseases, including Brody myopathy. NGS testing can identify both common and rare genetic variants in the ATP2A1 gene, providing a comprehensive analysis of the patient’s genetic profile.

NGS genetic testing for Brody myopathy typically involves collecting a blood or saliva sample from the patient, which is then analyzed using advanced sequencing technology. The results of the test can help diagnose Brody myopathy, guide treatment decisions, and inform genetic counseling for the patient and their family members.